Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ACAD |
---|---|---|
09:32 ET | 5898 | 15.93 |
09:34 ET | 500 | 15.845 |
09:36 ET | 100 | 15.8325 |
09:38 ET | 500 | 15.83 |
09:39 ET | 400 | 15.84 |
09:41 ET | 1122 | 15.85 |
09:43 ET | 3112 | 15.89 |
09:45 ET | 2367 | 15.905 |
09:48 ET | 800 | 15.86 |
09:50 ET | 600 | 15.81 |
09:52 ET | 400 | 15.825 |
09:54 ET | 515 | 15.78 |
09:56 ET | 710 | 15.775 |
09:57 ET | 1100 | 15.775 |
09:59 ET | 959 | 15.735 |
10:01 ET | 1962 | 15.79 |
10:03 ET | 3037 | 15.77 |
10:06 ET | 1224 | 15.76 |
10:08 ET | 1100 | 15.785 |
10:10 ET | 2097 | 15.78 |
10:12 ET | 100 | 15.78 |
10:14 ET | 1310 | 15.7696 |
10:15 ET | 2512 | 15.81 |
10:17 ET | 2031 | 15.82 |
10:19 ET | 981 | 15.81 |
10:21 ET | 600 | 15.81 |
10:24 ET | 200 | 15.82 |
10:28 ET | 4481 | 15.8 |
10:30 ET | 800 | 15.8 |
10:32 ET | 2932 | 15.77 |
10:33 ET | 400 | 15.77 |
10:35 ET | 2988 | 15.76 |
10:37 ET | 1500 | 15.72 |
10:39 ET | 2144 | 15.73 |
10:42 ET | 684 | 15.72 |
10:44 ET | 2853 | 15.7 |
10:46 ET | 5249 | 15.69 |
10:48 ET | 300 | 15.69 |
10:50 ET | 785 | 15.6985 |
10:51 ET | 1343 | 15.68 |
10:53 ET | 4443 | 15.64 |
10:55 ET | 1700 | 15.65 |
10:57 ET | 1100 | 15.62 |
11:00 ET | 2798 | 15.64 |
11:02 ET | 1100 | 15.63 |
11:04 ET | 2616 | 15.63 |
11:06 ET | 4061 | 15.58 |
11:08 ET | 2741 | 15.6 |
11:09 ET | 700 | 15.62 |
11:11 ET | 800 | 15.62 |
11:13 ET | 1043 | 15.605 |
11:15 ET | 4900 | 15.625 |
11:18 ET | 600 | 15.6 |
11:20 ET | 1043 | 15.61 |
11:22 ET | 1135 | 15.64 |
11:24 ET | 2461 | 15.61 |
11:26 ET | 636 | 15.6 |
11:27 ET | 1144 | 15.59 |
11:29 ET | 1176 | 15.595 |
11:31 ET | 744 | 15.59 |
11:33 ET | 300 | 15.59 |
11:36 ET | 200 | 15.59 |
11:38 ET | 4147 | 15.61 |
11:40 ET | 1035 | 15.585 |
11:42 ET | 500 | 15.5867 |
11:44 ET | 1400 | 15.58 |
11:45 ET | 2385 | 15.57 |
11:47 ET | 2367 | 15.56 |
11:49 ET | 100 | 15.57 |
11:51 ET | 405 | 15.57 |
11:54 ET | 2407 | 15.575 |
11:56 ET | 540 | 15.565 |
11:58 ET | 200 | 15.565 |
12:00 ET | 1388 | 15.575 |
12:02 ET | 1460 | 15.56 |
12:03 ET | 400 | 15.565 |
12:05 ET | 4602 | 15.53 |
12:07 ET | 19597 | 15.6 |
12:09 ET | 2823 | 15.58 |
12:12 ET | 350 | 15.58 |
12:14 ET | 2879 | 15.585 |
12:16 ET | 2345 | 15.59 |
12:18 ET | 3334 | 15.56 |
12:20 ET | 3108 | 15.54 |
12:21 ET | 829 | 15.54 |
12:23 ET | 1650 | 15.53 |
12:25 ET | 2410 | 15.545 |
12:27 ET | 750 | 15.53 |
12:30 ET | 2846 | 15.54 |
12:32 ET | 4020 | 15.57 |
12:34 ET | 1940 | 15.58 |
12:36 ET | 1726 | 15.575 |
12:38 ET | 1910 | 15.56 |
12:39 ET | 13767 | 15.56 |
12:41 ET | 3723 | 15.585 |
12:43 ET | 838 | 15.58 |
12:45 ET | 5704 | 15.585 |
12:48 ET | 6265 | 15.6 |
12:50 ET | 2918 | 15.59 |
12:52 ET | 3147 | 15.615 |
12:54 ET | 4168 | 15.635 |
12:56 ET | 5425 | 15.605 |
12:57 ET | 10985 | 15.615 |
12:59 ET | 100158 | 15.59 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
ACADIA Pharmaceuticals Inc | 2.6B | -1,211.3x | --- |
Azenta Inc | 2.8B | -19.0x | --- |
PTC Therapeutics Inc | 2.4B | -4.0x | --- |
Guardant Health Inc | 3.5B | -7.2x | --- |
Amicus Therapeutics Inc | 2.9B | -19.9x | --- |
Novavax Inc | 1.8B | -4.0x | --- |
Acadia Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has a portfolio of commercial stage products, in-development product opportunities, and research programs that are designed to address unmet needs in CNS disorders and rare diseases. Its pipeline includes NUPLAZID (pimavanserin), DAYBUE (trofinetide), ACP-101, ACP-204, and Antisense Oligonucleotide (ASO) Programs. NUPLAZID is a selective serotonin inverse agonist/antagonist preferentially targeting the 5-HT2A receptor. NUPLAZID is developed for the treatment for Parkinson's Disease Psychosis. Trofinetide is a novel synthetic analog of the amino-terminal tripeptide of insulin-like growth factor 1 (IGF-1) designed to treat the core symptoms of Rett syndrome by reducing neuroinflammation and supporting synaptic function.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.6B |
---|---|
Revenue (TTM) | $813.8M |
Shares Outstanding | 165.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.38 |
EPS | $-0.01 |
Book Value | $2.62 |
P/E Ratio | -1,211.3x |
Price/Sales (TTM) | 3.2 |
Price/Cash Flow (TTM) | 288.0x |
Operating Margin | -0.56% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.